Skip to main content

Advertisement

Table 3 The effects of endoscopic therapies on variceal recurrence after esophageal variceal eradication

From: The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study

  EVL group (n = 54) EIS group (n = 80) EVL + EIS group (n = 19) P value
Course number of endoscopic treatment course to variceal eradication 1.9 ± 0.7 3.2 ± 1.2a 3.4 ± 1.6a 0.00
Median time of variceal recurrence(month) 10 13a 12 0.01
EUS findings
 diameter of peri-ECV(mm) 2.9 ± 1.4 3.4 ± 1.5 2.9 ± 1.1 0.14
 diameter of PFV(mm) 1.44 ± 1.5 0.9 ± 1.5 1.0 ± 1.3 0.15
 existence or not of PFV(Y/N,n) 29/25 24/56a 6/13 0.01
 diameter of para-ECV(mm) 6.2 ± 2.1 6.3 ± 2.3 6.3 ± 2.4 0.83
Esophageal stenosis(Y/N,n) 0/54 9/71a 0/19 0.01
Child-Pugh grade(n,%) 0.21
 A 29, 53.7 57, 71.3 10, 52.6  
 B 20, 37.0 16, 20 7, 36.9
 C 5, 9.3 7, 8.7 2, 10.5
Child-Pugh score 7.2 ± 2.1 6.7 ± 1.7 7.2 ± 1.9 0.36
Portal vein embolus(Y/N, n) 10/44 24/56 4/15 0.29
With liver cancer (n,%) 7, 13.0 9, 11.3 3,15.8 0.85
Unknown causes for cirrhosis 0 2 1
  1. aCompared with EVL group